Innovative Partnership Nominated for Citeline Award

CISCRP proudly participated in a 2019 collaboration with Biogen, the National Minority Quality Forum (NMQF), Tufts Center for the Study of Drug Development (CSDD), Langland, H.E.A.L. and the FDA’s Office of Minority Health and Health Equity to engage directly with the general public through grass-roots outreach campaigns and events; to listen to their level of understanding, awareness, and concerns through digital channels, in-person meetings and interviews; and to provide resources to support education about clinical research participation. These efforts proved valuable and impactful, receiving endorsement to continue to build and expand these efforts in 2020 and beyond. This innovative 2019 project has recently been nominated as a finalist in the 2020 Citeline Awards for Medidata Clinical Partnership of the Year.

The team worked to better understand the challenges and barriers encountered by African American and Hispanic/Latinx communities in the US regarding awareness, access to clinical research participation, and health care provider involvement in evaluating research opportunities. 

As a part of this large engagement campaign, Tufts CSDD conducted in-depth interviews among minority physicians, investigators and nurses to explore barriers and challenges to clinical trial access and referral, as well as high incidence of minority investigator drop-out rates. An online social listening campaign was launched to follow conversations and sentiments around clinical trials among African Americans and Hispanic/Latinx communities. CISCRP and the NMQF organized public-facing programs that offered free health screenings and educational sessions. The FDA participated in Biogen’s Patient Engagement Day and spoke to the importance of engaging underrepresented minorities in clinical trials.

Insights obtained from these conversations will assist the team in enhancing current structures and implementing new efforts to increase access to clinical trial sites and site participation in clinical trials. Feedback provided by online social listening and healthcare providers reinforced existing barriers to clinical research participation for members of diverse communities.

“While the public continues to acknowledge the importance of clinical research in identifying new medicines, general awareness and participation in clinical research studies remain low for a variety of reasons, and minority populations continue to be underrepresented in clinical trials,” said Ellyn Getz, Associate Director, Development and Community Engagement for CISCRP. “Many learnings from this year-long program will be applied in 2020 to patient engagement strategies, protocol entry criteria, site selection, and patient outreach.”

In 2019, approximately 2,000 people attended NMFQ’s community health events and CISCRP’s AWARE for All programs and learned about clinical trial participation. Over 500 event attendees surveyed indicated that they are somewhat or very interested and willing to participate in a clinical trial and are eager to participate if invited by their health care provider. This indicates an opportunity to further engage, educate, and connect underrepresented patients with clinical trial site teams.

This innovative collaboration has built a strong foundation for continued grass-roots outreach efforts. Biogen is supporting the AWARE for All: Clinical Research Education event series over the next five years as a member of CISCRP’s AWARE Industry Consortium. The consortium addresses the critical need to improve patient diversity in clinical trials.

For more information, please contact Joan Chambers, CISCRP’s Senior Director, Marketing and Outreach, at jchambers@ciscrp.org or Ellyn Getz, Associate Director, Development & Community Engagement, at ellyngetz@ciscrp.org.

CISCRP Announces 2nd Annual Virtual Fitness Challenge to Recognize Medical Heroes

Encouraging the clinical research community to come together across the globe to honor medical and healthcare professionals, researchers and study volunteers

Boston, MA | April 2, 2020

On April 15, the Center for Information & Study on Clinical Research Participation (CISCRP) will be initiating the 2nd annual Medical Hero Appreci-a-thon to bring the global clinical research community together to express their appreciation for all “Medical Heroes” – medical and healthcare professionals, researchers and study volunteers.  CISCRP invites the public to participate in this free month-long virtual fitness opportunity.

Participants can share the distance they will go to recognize Medical Heroes by tracking any form of exercise—cycling, running, elliptical, weightlifting, sit-ups, yoga, stair climbing, pet-walking and other physical activities—on the Appreci-a-thon portal. Donations received in support of the virtual fitness challenge provide educational programs designed to help patients and their families navigate the clinical research process.

“Last year, nearly 400 people across industry, research, advocacy, and patient communities participated globally in this virtual appreciation event and the spirit of support and teamwork was inspiring,” said event organizer Justine Holleran. “This year we’re hoping to see an even larger community participating in this virtual fitness challenge to raise awareness about clinical research and its importance to public health.”

“Clinical research education and awareness is even more critical today,” added Ellyn Getz, Associate Director, Development and Community Engagement, at CISCRP.  “Medical, healthcare and research professionals are working tirelessly to provide care and treatment. And patients, their families and the public are seeking information and hope. Join us in showing your support and appreciation for the many dedicated ‘Medical Heroes’ around the world by participating in this virtual fitness challenge!”

The Medical Hero Appreci-a-thon virtual fitness challenge officially starts April 15th and runs through May 15th. Participants can register for free at https://www.ciscrp.org/events/appreci-a-thon.

For additional information, email medicalheroevents@ciscrp.org or visit https://www.ciscrp.org/events/appreci-a-thon

ABOUT CISCRP:

The Center for Information and Study on Clinical Research Participation is an award-winning nonprofit organization dedicated to educating and engaging the public, patients, research and health care professionals as partners in the clinical research process. Since 2003, CISCRP has produced numerous educational and awareness-building programs internationally and has developed a large library of print/digital content to increase health literacy.

New Consortium Launched In Partnership with CISCRP to Improve National Clinical Research Literacy

Research in the literature shows that minority communities have a high willingness to participate in clinical trials and high self-reported general knowledge about the clinical research process. Yet, according to a recent study conducted by the Center for the Study of Drug Development at the Tufts University School of Medicine, minority patients – most notably those of Black and African descent– are highly underrepresented in clinical trials of new medical interventions. Tufts research also shows that patient referral rates into clinical trials among practicing minority physicians and nurses are very low.

To address the critical need to improve patient diversity in clinical trials, CISCRP – in partnership with ten leading pharmaceutical companies and clinical research service providers – has launched a new consortium that will focus energy and resources on community-based education during the next five years beginning in early 2020. Consortium members include Merck, IQVIA, Biogen, Otsuka, CSL Behring, Janssen, WCG, Boston Scientific, EMD Serono, and Pfizer. Representatives from each member company will participate on a steering committee and will provide staff and resources to support the planning and execution of live educational events in five targeted urban centers annually.

“This centralized approach is vital to bring together the necessary oversight and infrastructure required to engage with communities from around the country,” said Jonathan Jackson, Ph.D., study volunteer and The Center Director of Community Access, Recruitment, and Engagement (CARE) Research Center at the Massachusetts General Hospital, Harvard Medical School.

The Consortium initiative builds on CISCRP’s 18-year experience producing and hosting internationally recognized live educational events – called AWARE-for-ALL programs — throughout the United States and parts of Europe. Each event engages a local planning committee comprised of members of the public, patients, advocacy groups, health care and clinical research professionals, offers educational presentations and discussions, as well as free health screenings and information about local clinical trial activity. The consortium also plans to mobilize a pop-up educational exhibit in targeted urban health centers to generate excitement and awareness in the weeks leading up to each live event.

“We are thrilled to be working with Consortium members on this important and novel initiative,” said Ellyn Getz, Associate Director of Development & Community Engagement at CISCRP. “Support, input and insight from consortium members presents an unprecedented opportunity to have an even greater impact on advancing public and patient clinical research literacy over a 5-year time period with ongoing continuous improvement,” she added.

ABOUT CISCRP:

The Center for Information and Study on Clinical Research Participation (CISCRP) is an internationally recognized 501(c)(3) non-profit organization dedicated to educating, informing and engaging the public

and patients about clinical research. CISCRP is committed to providing services designed to help professionals best engage patients as partners in the clinical research process. Visit www.CISCRP.org .

Contact Information
Joan A. Chambers
Senior Director, Marketing & Outreach
CISCRP

Phone: 617-725-2750 ext. 202

www.CISCRP.org

 

Letter from the Editor, November 2016

Rachel MinnickThe weather is starting to cool and as fall greets us, it is a wonderful time to reflect on the events of the past year and begin to gear up for new and exciting opportunities ahead. I’d like to introduce myself as the new Editor of the Patients as Partners Newsletter. I’m thrilled to have the opportunity to share exciting news and updates about CISCRP through this platform and want to thank you in advance for your readership.

2016 has been a tremendous year of growth for CISCRP’s educational programs and patient outreach initiatives. Among our many initiatives, a few highlights: We held a record number of AWARE for All events this year, including our first international program in the UK; hosted two Medical Hero Appreciation 5K Events, both of which welcomed over 300 runners/walkers each; co-hosted the first “Inspiring Hope” Ideathon to generate innovative ideas to raise clinical research awareness; conducted thousands of free clinical trial searches for patients; participated in countless speaking engagements, webinars, and symposium; and distributed thousands of educational materials to sites and organizations world-wide.

This year has also seen significant growth in our Communicating Trial Results program and in our Patient Advisory Board services. More and more companies are turning to CISCRP for assistance in improving their patient engagement capabilities.

In 2017, we will be holding AWARE for All events in New Orleans, Seattle, Houston, Jacksonville, and in Manchester, England and Toronto, Canada! Check our upcoming events page for date announcements!
As a final note, I’m delighted to announce that CISCRP is moving! As our organization continues to grow and expand, we are excited to move into a larger office space within the Boston area. The move is planned for early 2017 and we will be sure to share our new address and location with our supporters as soon as the details are finalized.

As I reflect on an exciting year behind and ahead, I want to note that all of our efforts are made possible by you, our generous supporters, donors, and collaborators. We are so thankful for your dedication to helping us raise awareness and education around clinical research!

I wish you all the best and hope you will keep CISCRP in your thoughts.

Thanks for reading,

Rachel

Letter from the Editor, March 2017

Rachel Minnick

Dear Readers,

We are well into the New Year and 2017 is shaping up to be an exciting year for CISCRP, our educational programs, and our patient outreach and engagement initiatives.  I have some updates and information to share with you as we look to the year ahead of us.

This quarter’s newsletter will introduce a new “Supporter Spotlight” piece that we will include in each edition moving forward.  This will be an opportunity for us to feature a new CISCRP supporter and highlight their work and successes within the clinical research education and outreach space.  For our first spotlight piece, we are featuring Jennifer Byrne of PMG Research, who has been a long-time supporter of CISCRP.

As always, we have included our Medical Hero Spotlight piece, and this quarter we have the pleasure of introducing you to T.J. Sharpe, a Stage IV melanoma survivor, who shares his experiences with different clinical trials and how they ultimately saved his life.

We are delighted to highlight one of our growing Medical Hero Recognition initiatives, a program that includes publications in major national newspapers and one that helps to recognize and thank study volunteers for their participation in clinical research.

We have also included an article on CISCRP’s role in an exciting and important new grant project being spear-headed by the Lupus Foundation of America.  We are part of a team who is developing a new model for improving minority awareness and participation in lupus clinical trials.  Stay tuned for future updates on this ground-breaking initiative.

Lastly, we have some incredible ideas and options for how our community members and supporters can get more involved with CISCRP, be it through use of our educational materials or through creative ways to engage with us.  We want to work with you, as partners, in providing greater outreach and education to the clinical research community, patients, and the public.

In upcoming events news, CISCRP is gearing up for two Medical Hero 5K Walk/Run events on April 29th in Seattle WA and June 19th in Chicago, IL.  We are also hosting our first AWARE for All Clinical Research Education day of 2017 on May 12th in Houston, TX.   Be sure to check our Upcoming Events page for new AWARE for All city and date announcements, coming soon!

As we gear up for the year, I want to note that all of our efforts are made possible by you, our generous supporters, donors, and collaborators.  We are thankful for your dedication to helping us raise awareness about clinical research and the importance of clinical trial participation!

I wish you all the best and hope you will keep CISCRP in your thoughts.

Thanks for reading,

Rachel

CISCRP’s Educational Materials to Promote Greater Literacy and Awareness of Clinical Research

CISCRP’s Educational Center is a free online resource for learning more about clinical research and clinical trial participation.  The education center contains a wealth of information to inform patients and the public about clinical research, including FAQs, interactive videos, volunteer perspectives, charts and statistics, downloadable reference guides, and much more.  We encourage potential study volunteers to spend some time educating themselves about clinical research before making an informed decision to participate.  And we encourage sites and researchers to direct study volunteers to our site to learn more about clinical trial participation and the overall clinical research process.

Our education center is always growing and evolving to ensure that we have relevant and timely information about clinical trials available to patients and the public.  We are pleased to introduce a new set of digital brochures that will soon be available in the Education Center on the topics of “Taking Part in a Clinical Trial” and “Let Us Recognize and Thank Study Volunteers.”  These are intended to help patients and family members become more informed and educated about clinical research.  They can also be used as a reference by sites and research institutions.  These will be available to download so that patients may take them as a reference when speaking to their study staff about a clinical trial or to their doctor about clinical research participation options.  They will also be available in print form through the CISCRP Store.

These new brochures were developed in sponsorship with INC Research; a leading global contract research organization (CRO) (www.Incresearch.com).  Christine Phillips, MSc, PhD, Senior Director with INC Research comments, “INC is pleased to work with CISCRP to bring new educational pieces to the CISCRP Education Center and Store.  We plan to use these new brochures at our own sites to give patients access to more information about clinical trial participation and the importance of recognizing study volunteers as “medical heroes.””

CISCRP is pleased to provide these and other valuable resources to patients, family members, and the general public so that potential study volunteers can educated themselves and their support team on the clinical research process.  Providing clinical trial education is key to empowering patients to feel that they are engaged and valued partners in the clinical research process.

All of our educational brochures are available to purchase in print form through the CISCRP Store.  We also offer co-branding options for all of our Store materials for sites or companies who wish to add their logo and contact information to the material.  Contact CISCRP for more information!

We are always looking to expand our library of materials and encourage more companies to reach out to CISCRP to develop new educational materials.  Below is a listing of our current brochures and content.  If your company is interested in sponsoring the development of new content, please contact Rachel Minnick at rminnick@ciscrp.org or 617-725-2750 x330.

Should I Participate
Should My Child Participate
African Americans and Clinical Research
Los Hispanos y la Investigacion Clinica
What is a Placebo and Why Are They Used in Clinical Trials
Debunking Common Myths About Clinical Trials
Taking Part in a Clinical Trial (new Store item)
Let Us Recognize and Thank Study Volunteers (new Store item)

Creative Ways to Support CISCRP

By Ellyn Getz

Our supporters have structured their philanthropic campaigns in many creative ways, from product licenses for educational content to point-of-sale programs where a specific percentage or dollar amount is allocated to CISCRP. We also hold many high-profile special events during the year and welcome business sponsorships.

In 2016, we received many exceptional and unique suggestions that companies implemented as ways to support CISCRP’s educational and outreach initiatives.

Here are just a few ways that a number of members in our Circle of Supporters built support for CISCRP into their budgets and campaigns:

Every Holiday Card Share = Donation to CISCRP
INC Research developed an end-of-year holiday card campaign to spread good cheer…while increasing clinical research literacy in the process. Every time their digital holiday card was shared, INC the donated $1 to CISCRP. Thanks to INC and their supportive community, they generated a $5000 end-of-year donation for CISCRP that will be put towards 2017 education and outreach programs.

INC card

 

USA Today Editorial Piece: In-Kind Marketing Support
Each year, CISCRP develops a full-page ad to thank study volunteers – Medical Heroes – in a USA Today supplement. In both 2015 and 2016, Praxis has donated in-kind marketing support to develop and publish this important educational content.

12   122

 

Piggy-Backing a Team-Building Activity, with Free Breakfast & Backpacks for All
DrugDev decided to take their Medical Heroes Appreciation 5K support to the next level in 2016. They exceeded their 100-person goal by inviting all of their employees and their families to participate in the Philadelphia-based 5K. DrugDev welcomed all participants by sponsoring a free breakfast and distributing branded backpacks as part of the 5K give-away packets.

001

 

Leveraging Current Marketing Momentum to Build Excitement
The Segal Institute not only shared their excitement to host sponsor an AWARE for All in Miami by sending an army of Segal staff to volunteer onsite at the program, covering parking for all attendees, and sending out a text message to their entire patient database with an invitation to be honored at the upcoming free educational program – they also donated public transit ad space that they normally used to promote their research program for a whole month leading up to the event.

Amplifying the Patient Voice – Hosting Global Road Shows
CISCRP hosts roundtables in the US and Europe to present new data and insights on public and patient attitudes and experiences, and since 2014, Acurian has sponsored 2.5 hour interactive roundtables, open to regionally-located professionals. Recently, Acurian proposed hosting onsite meetings at pharmaceutical company headquarters, as a session during a company-wide conference. The two teams have co-presented to five different companies in the past year, offering robust data analyses and application to aid engagement decisions among clinical operations teams.

Further Incentives to Participate in Online Industry Surveys and Visiting Booth at Conferences
Advanced Clinical conducts a number of industry surveys on innovation and technology. As a further incentive for individuals to participate, Advanced Clinical promotes offering a donation to CISCRP on their behalf. Additionally, Advanced Clinical invites individuals to their exhibit booth at trade conferences and offers to give them a Medical Hero button as well as make a donation to CISCRP on their behalf.

How Can We Count on Your Help and Creativity in the New Year?
CISCRP is looking to connect with new supporters for 2017/2018 patient-engagement initiatives. We have a number of ideas – like hosting a team-building, highly-visible 5K on your company’s campus, sponsoring AWARE for All events abroad, developing new educational content and programs, etc. – and we welcome your creative and innovative ideas as well! To start the process and discuss ways in which your company can support our mission of engaging patients as partners in the clinical research process, please contact ellyngetz@ciscrp.org or call 617-725-2750 x320. We can’t wait to work with you!

A Young Father Opts for Clinical Research When Standard of Care is “Not Acceptable”

By Shelly Reese

Like any father of a newborn and a toddler, T.J. Sharpe assumed his fatigue was due to sleepless nights. So when a sudden high fever sent him to the emergency room in August 2012 he was blindsided by the diagnosis: his cancer had come back.

Twelve years earlier T.J. had had a stage 1B melanoma removed from his chest. The procedure had gone well, and T.J. had been careful about his sun exposure ever since. But the health scare he thought was behind him was back with a vengeance: his cancer had metastasized. Scans showed he had spots on his lungs, tumors in his liver and spleen, and a large mass on his small intestine, which was causing internal bleeding.

T.J. spent 16 days in the hospital and had the tumor surgically removed, but when the oncologist spoke grimly about what he might expect from standard of care treatments, the young father decided it was time to chart a new course.

“He told my wife he’d be surprised if I was around in two years,” recalls T.J. “Standard of care was not acceptable. I needed something that was going to give me the best chance of a long-term response. I wanted a chance to see my kids grow up. To see them go to college and get married.”

T.J. and his wife, Jen, sought four more medical opinions, ultimately settling on an experimental immunotherapy treatment at Moffitt Cancer Center in Tampa. The family rented a house nearby so T.J. could undergo the new regimen, which involved a combination of immunotherapy and tumor-infiltrating lymphocyte (TIL) harvested from a tumor on his lung. The trial was a challenge: T.J. developed diverticulitis, which required a colostomy, and ultimately he did not respond to treatment.

“I was the first to try this, and I was the first to fail it.”

With the help of a friend at the Melanoma International Foundation, T.J. found a new trial at Holy Cross Hospital just miles from his home in Ft. Lauderdale and it was accepting new participants.

Although the local cancer center did not have Moffitt’s size or reputation, “They had the drug, which meant we could started right away, and we could move home,” says T.J. “That was important. It was a decision not to let our lives be completely run by my diagnosis and treatment.”

Soon after T.J. received his first dose of Merck’s lambrolizumab, an investigational antibody therapy later renamed pembrolizumab. His reaction was profound and almost immediate. Within a matter of weeks his tumors had shrunk by half.

Today T.J. blogs for the Philadelphia Inquirer’s web site about his experience. Every three weeks he continues to undergo a 30-minute infusion treatment of pembrolizumab, which has since earned FDA approval. Since starting the trial he has experienced occasional fatigue and nausea, small patches of vitiligo (a loss of skin pigmentation) and a painful case of shingles. Despite the side effects, he says he generally feels better than he’s felt in years.

Best of all, at 41 he’s able to live his life the way he wants.

“I coach both kids’ soccer teams,” he says happily. “Four and a half years ago if you had told me, ‘You are going to end up spending your time running from field A to field B with a bag of soccer balls.’ I would have thought, ‘That’s a pretty good ending to the story.’”

Throughout his journey T.J. has had to make difficult choices, first in rejecting standard-of-care therapy and later in deciding to leave a highly regarded cancer center. Researching his options, seeking additional opinions and doing his homework enabled him to make the right decisions, he says.

“To anyone with a serious diagnosis I would say, ‘Be your own advocate.’ It sounds cliché, but ultimately the decisions on treatment are yours alone to make. You will consult with very smart doctors, but your health is yours and yours only,” he says. “An informed patient that has been able to get more than one opinion and understands the diagnosis knows what their options are and can make the right decision for them.”

Empowerment Through Participation: A Parkinson’s Patient Shares His Advocacy Story

By Rachel Minnick

When Don Simmonds was diagnosed with Parkinson’s Disease at age 73, clinical trials were on the forefront of his mind. Upon his first meeting with his specialist, Dr. Goetz suggested that Don would be a good candidate for a clinical trial. A quick exchange with his wife Noreen made the decision to participate clear – “she said, ‘if you’re not going to do this, we’re going to have a talk,’” he said. “I didn’t want to have a talk so I signed up.”

Don describes Parkinson’s as a “highly individualized disease” – people with the disease can experience a broad range and severity of symptoms, leaving a lot to still be learned by doctors and scientists. Don is happy to step up and be part of that movement toward new treatments and a cure, saying it’s “the least [he] can do,” especially because the slow progression of his disease makes its effects “minimal” on his daily life.

Don feels empowered to do his part in the Parkinson’s research arena by participating in clinical trials. If he didn’t, he says, then who would? He shared a shocking statistic that resonates with our work at CISCRP; only 1% of Parkinson’s patients participate in research, he tells me. “I’m happy to be part of the 1%,” he says. “I may not be part of the wealthy 1%, but it’s this that really matters to me.”

And being part of clinical studies doesn’t just benefit the research community. Right now, Don is taking part in a 3-year study on cognition in Parkinson’s Disease patients, a topic that’s fascinating to him as he enters his final year in the study. “I’m curious to see my results. I feel pretty sharp so it will be interesting to see if I’ve lost some cognition during the past few years.”

Aside from his role as a clinical trial participant in more than 7 studies, Don does even more to support research by volunteering as an advocate for the Parkinson’s Disease Foundation (PDF).

Shortly after his diagnosis, a chance to complete training and become a PDF Parkinson’s Advocates In Research (PAIR) member provided him the unique ability to connect with other People with Parkinson’s across the United States and spread information about the disease with others in support groups and in public places like hospitals and libraries. A minister in his younger life, Don enjoys the opportunity to speak out about important issues and help those who share a similar struggle.

Don – with Noreen by his side – does his important work in his local Chicago area and around the country. They attended the World Parkinson’s Congress in Portland, Oregon in September, and Don has shared his story at numerous meetings and events, including CISCRP’s AWARE for All Chicago program in 2015.

Don hopes to keep “pitching in” and doing what he can to support Parkinson’s research. “It’s rewarding,” he says, to know that just one person can make a difference – for the advancement of medicine and for the millions of other People with Parkinson’s who benefit.

Communicating Trial Results: A Growing Need for Industry

By Rachel Minnick

Since 2009, CISCRP has been working with pharmaceutical, biotechnology and medical device companies to create and disseminate plain language summaries for clinical trial participants under its Communicating Trial Results program. During the past seven year we have seen tremendous interest and growth in the program as more sponsor companies pilot and adopt this initiative among their patient engagement practices. There has been a significant call-to-action to include Communicating Trial Results programs to support clinical trial transparency, and to demonstrate that study volunteers are valued partners in the clinical research process.

At the present time, CISCRP is working with more than 30 major sponsor companies to provide trial results summaries on a study-specific basis and increasingly under portfolio-wide arrangements. CISCRP’s plain language summaries are offered in paper and digital formats.

Communicating Trial Results programs are essential to building trust among patients. Many sponsors will soon be a required to submit their lay language summaries to the online EU Public Portal under the new European Union Clinical Trials Regulation. Although the FDA has not mandated that sponsors provide lay language summaries, a growing number of companies anticipate that doing so will become a standard practice in the United States.

During the past 24 months, CISCRP’s team supporting the Communicating Trials Results program has grown dramatically. The team includes dedicated regulatory writers, senior editors with expertise in plain language communication principals, and patient representatives.

Jill McNair, Senior Director of Patient Engagement who oversees the Communicating Trials Results program at CISCRP, remarked “We’re working with a growing number of sponsor companies who recognize that communicating trial results is not only the ethical thing to do but also the right thing to do. We’re helping sponsor companies integrate this important process into their clinical research operations to drive higher levels of patient engagement.”

CISCRP is also leveraging its well-established Communicating Trials Results processes and dedicated editorial panels to help companies apply similar principles to other important plain-language clinical trial communications including informed consent documents, risk management summaries, and ongoing communications.

CISCRP’s is honored to have its award-winning Communicating Trial Results program recognized as a leading service and an emerging standardized practice. For more information, contact Jill McNair (JillMcNair@ciscrp.org) or go to Communicating Trial Results.